4.6 Article

Targeting different domains of gap junction protein to control malignant glioma

Journal

NEURO-ONCOLOGY
Volume 20, Issue 7, Pages 885-896

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/neuonc/nox207

Keywords

carboxyl terminal; channel structure; Cx43; glioma; therapeutics

Funding

  1. National Key Research and Development Program of China [2016YFA0202104]
  2. National Natural Science Foundation of China [81572880, 81172071, 81302193]
  3. Outstanding Youth Science Foundation of Chongqing [CSTC2013JCYJJQ10003]
  4. Postgraduate Education Foundation of Chongqing [YJG153062]
  5. Key Clinical Research Program of Southwest Hospital [SWH2016ZDCX1005]

Ask authors/readers for more resources

A rational treatment strategy for glioma, the most common primary central nervous system tumor, should focus on early invasive growth and resistance to current therapeutics. Connexin 43 (Cx43), a gap junction protein, plays important roles not only in the development of the central nervous system and but also in the progression of glioma. The different structural domains of Cx43, including extracellular loops, transmembrane domains, and an intracellular carboxyl terminal, have distinct functions in the invasion and proliferation of gliomas. Targeting these domains of Cx43, which is expressed in distinct patterns in the heterogeneous glioma cell population, can inhibit tumor cell invasion and new tumor formation. Thus, this review summarizes the structural characteristics of Cx43, the effects of regulating different Cx43 domains on the biological characteristics of glioma cells, intervention strategies targeting different domains of Cx43, and future research directions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available